Skip to main content

Table 1 Patient and tumour characteristics

From: Clinical image quality perception and its relation to NECR measurements in PET

 

Value

Number of patients

71

Pathologic lesion, n (%)

 

 Yes

42 (59.2)

 No

29 (40.8)

Indication, n (%)

 

 Primary staging

16 (22.5)

 Follow-up/re-staging

53 (74.6)

 Non-oncological (FUO and aortic aneurysm graft)

2 (2.8)

Tumour type, n

 

 Lymphoma (NHL/HD)

18 (11/7)

 Lung cancer (proved/suspicious/incidental)

13 (10/2/1)

 Breast cancer

9

 Melanoma

7

 Renal cell

3

 Oesophagus, larynx, stomach

2

 Adrenal, anal, colon, fibrosarcoma, follicular thyroid, hypopharynx, nasopharynx, oropharynx, ovarian, paraganglioma, myeloid sarcoma, mesothelioma, rectal, SCC right upper arm

1

Under therapy, n (%)

 

 Yes

13 (18.3)

 No

56 (78.9)

 N/A

2 (2.8)

  1. FUO, fever of unknown origin; NHL, non-Hodgkin lymphoma; HL, Hodgkin lymphoma; SCC, squamous-cell carcinoma; N/A, not applicable.